Patent applications and USPTO patent grants for Boehringer Ingelheim (Canada) Ltd..The latest application filed is for "viral polymerase inhibitors".
Patent | Date |
---|---|
Self-replicating RNA molecule from hepatitis C virus Grant 7,919,312 - Kukolj , et al. April 5, 2 | 2011-04-05 |
Hepatitis C inhibitor tri-peptides Grant RE42,164 - Llinas-Brunet , et al. February 22, 2 | 2011-02-22 |
Viral polymerase inhibitors Grant 7,893,084 - Beaulieu , et al. February 22, 2 | 2011-02-22 |
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease Grant 7,838,207 - Pellerin , et al. November 23, 2 | 2010-11-23 |
Hepatitis C inhibitor tri-peptides Grant RE41,894 - Llinas-Brunet , et al. October 26, 2 | 2010-10-26 |
Inhibitors of papilloma virus Grant 7,807,670 - Yoakim , et al. October 5, 2 | 2010-10-05 |
Hepatitis C inhibitor tri-peptides Grant RE41,356 - Llinas-Brunet , et al. May 25, 2 | 2010-05-25 |
Viral polymerase inhibitors Grant 7,576,079 - Beaulieu , et al. August 18, 2 | 2009-08-18 |
Inhibitors of papilloma virus Grant 7,528,167 - Yoakim , et al. May 5, 2 | 2009-05-05 |
Viral Polymerase Inhibitors App 20090087409 - Beaulieu; Pierre Louis ;   et al. | 2009-04-02 |
Viral polymerase inhibitors Grant 7,439,258 - Beaulieu , et al. October 21, 2 | 2008-10-21 |
Hepatitis C inhibitor tri-peptides Grant RE40,525 - Llinas-Brunet , et al. September 30, 2 | 2008-09-30 |
Self-replicating RNA molecule from hepatitis C virus Grant 7,344,723 - Kukolj , et al. March 18, 2 | 2008-03-18 |
RSV polymerase inhibitors Grant 7,323,567 - Simoneau , et al. January 29, 2 | 2008-01-29 |
Direct binding assay for identifying inhibitors of HCV polymerase Grant 7,294,457 - Kukolj , et al. November 13, 2 | 2007-11-13 |
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease Grant 7,276,373 - Pellerin , et al. October 2, 2 | 2007-10-02 |
Non-nucleoside reverse transcriptase inhibitors Grant 7,273,861 - Yoakim , et al. September 25, 2 | 2007-09-25 |
Purified active HCV NS2/3 protease Grant 7,264,811 - Lamarre , et al. September 4, 2 | 2007-09-04 |
Purified active HCV NS2/3 protease App 20070172936 - Thibeault; Diane ;   et al. | 2007-07-26 |
Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates Grant 7,167,801 - Cameron , et al. January 23, 2 | 2007-01-23 |
Viral polymerase inhibitors Grant 7,157,486 - Beaulieu , et al. January 2, 2 | 2007-01-02 |
Viral polymerase inhibitors Grant 7,141,574 - Beaulieu , et al. November 28, 2 | 2006-11-28 |
Self-replicating RNA molecule from hepatitis C virus App 20060246424 - Kukolj; George ;   et al. | 2006-11-02 |
Inhibitors of Papilloma Virus App 20060235010 - Yoakim; Christiane ;   et al. | 2006-10-19 |
Macrocyclic peptides active against the hepatitis C virus Grant 7,119,072 - Llinas-Brunet , et al. October 10, 2 | 2006-10-10 |
Inhibitors of papilloma virus Grant 7,119,099 - Yoakim , et al. October 10, 2 | 2006-10-10 |
Non-nucleoside reverse transcriptase inhibitors Grant 7,105,510 - Yoakim , et al. September 12, 2 | 2006-09-12 |
Viral polymerase inhibitors App 20060160798 - Beaulieu; Pierre Louis ;   et al. | 2006-07-20 |
Regions of papilloma virus E1 helicase involved in E1 oligomerization App 20050287554 - Archambault, Jacques | 2005-12-29 |
RSV polymerase inhibitors App 20050239814 - Simoneau, Bruno ;   et al. | 2005-10-27 |
Self-replicating RNA molecule from hepatitis C virus Grant 6,956,117 - Kukolj , et al. October 18, 2 | 2005-10-18 |
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease App 20050227226 - Pellerin, Charles ;   et al. | 2005-10-13 |
Regions of papilloma virus E1 helicase involved in E1 oligomerization Grant 6,916,622 - Archambault July 12, 2 | 2005-07-12 |
Methods for determining ATPase activity and uses thereof Grant 6,852,501 - White February 8, 2 | 2005-02-08 |
Inhibitors of papilloma virus App 20050009855 - Yoakim, Christiane ;   et al. | 2005-01-13 |
E2 displacement assay for identifying inhibitors of HPV Grant 6,825,176 - White , et al. November 30, 2 | 2004-11-30 |
Viral polymerase inhibitors App 20040224955 - Beaulieu, Pierre Louis ;   et al. | 2004-11-11 |
Purified active HCV NS2/3 protease Grant 6,815,159 - Thibeault , et al. November 9, 2 | 2004-11-09 |
Assay for identifying inhibitors of HIV RT dimerization Grant 6,811,970 - Sluis-Cremer , et al. November 2, 2 | 2004-11-02 |
Self-replicating RNA molecule from hepatitis C virus App 20040203020 - Kukolj, George ;   et al. | 2004-10-14 |
Viral polymerase inhibitors Grant 6,794,404 - Beaulieu , et al. September 21, 2 | 2004-09-21 |
Self-replicating RNA molecule from hepatitis C virus App 20040180333 - Kukolj, George ;   et al. | 2004-09-16 |
Hepatitis C inhibitor peptides Grant 6,767,991 - Llinas-Brunet , et al. July 27, 2 | 2004-07-27 |
Non-nucleoside reverse transcriptase inhibitors App 20040132723 - Yoakim, Christiane ;   et al. | 2004-07-08 |
Inhibitors of papilloma virus Grant 6,759,409 - Yoakim , et al. July 6, 2 | 2004-07-06 |
Non-nucleoside reverse transcriptase inhibitors App 20040106791 - Yoakim, Christiane ;   et al. | 2004-06-03 |
Non-nucleoside reverse transcriptase inhibitors Grant 6,716,836 - Ogilvie , et al. April 6, 2 | 2004-04-06 |
Viral polymerase inhibitors App 20040024190 - Beaulieu, Pierre Louis ;   et al. | 2004-02-05 |
Non-nucleoside reverse transcriptase inhibitors Grant 6,673,791 - Ogilvie , et al. January 6, 2 | 2004-01-06 |
Macrocyclic peptides active against the hepatitis C virus App 20040002448 - Tsantrizos, Youla S. ;   et al. | 2004-01-01 |
Regions of papilloma virus E1 helicase involved in E1 oligomerization App 20040002059 - Archambault, Jacques | 2004-01-01 |
Viral polymerase inhibitors App 20030236251 - Beaulieu, Pierre Louis ;   et al. | 2003-12-25 |
Viral polymerase inhibitors App 20030232816 - Beaulieu, Pierre Louis ;   et al. | 2003-12-18 |
Macrocyclic peptides active against the hepatitis C virus App 20030224977 - Llinas-Brunet, Montse ;   et al. | 2003-12-04 |
Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents App 20030226157 - Jianmin, Duan | 2003-12-04 |
E2 displacement assay for identifying inhibitors of HPV App 20030194698 - White, Peter ;   et al. | 2003-10-16 |
Macrocyclic peptides active against the hepatitis C virus App 20030181363 - Llinas-Brunet, Montse ;   et al. | 2003-09-25 |
Viral polymerase inhibitors App 20030176433 - Beaulieu, Pierre Louis ;   et al. | 2003-09-18 |
Non-nucleoside reverse transcriptase inhibitors App 20030171363 - Ogilvie, William W. ;   et al. | 2003-09-11 |
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease App 20030162168 - Pellerin, Charles ;   et al. | 2003-08-28 |
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease App 20030162169 - Pellerin, Charles ;   et al. | 2003-08-28 |
Macrocyclic peptides active against the hepatitis C virus Grant 6,608,027 - Tsantrizos , et al. August 19, 2 | 2003-08-19 |
Self-replicating RNA molecule from hepatitis C virus App 20030148348 - Kukolj, George ;   et al. | 2003-08-07 |
Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents Grant 6,596,924 - Jianmin July 22, 2 | 2003-07-22 |
Direct binding assay for identifying inhibitors of HCV polymerase App 20030108862 - Kukolj, George ;   et al. | 2003-06-12 |
Assay for identifying inhibitors of HIV RT dimerization App 20030087379 - Sluis-Cremer, Nicolas ;   et al. | 2003-05-08 |
Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket App 20030082769 - Cameron, Dale R. ;   et al. | 2003-05-01 |
Hepatitis C inhibitor tri-peptides Grant 6,534,523 - Llinas-Brunet , et al. March 18, 2 | 2003-03-18 |
Viral polymerase inhibitors Grant 6,479,508 - Beaulieu , et al. November 12, 2 | 2002-11-12 |
Anti-herpesvirus compounds and methods for identifying, making and using same Grant 6,458,959 - Crute , et al. October 1, 2 | 2002-10-01 |
Viral polymerase inhibitors Grant 6,448,281 - Beaulieu , et al. September 10, 2 | 2002-09-10 |
Hepatitis C inhibitor tri-peptides Grant 6,420,380 - Llinas-Brunet , et al. July 16, 2 | 2002-07-16 |
Hepatitis C inhibitor tri-peptides Grant 6,410,531 - Llinas-Brunet , et al. June 25, 2 | 2002-06-25 |
Hepatitis C inhibitor tri-pepitides Grant 6,329,417 - Llinas-Brunet , et al. December 11, 2 | 2001-12-11 |
Hepatitis C inhibitor tri-peptides Grant 6,329,379 - Llinas-Brunet , et al. December 11, 2 | 2001-12-11 |
Hepatitis C inhibitor tri-peptides Grant 6,323,180 - Llinas-Brunet , et al. November 27, 2 | 2001-11-27 |
Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain Grant 6,313,095 - Adams , et al. November 6, 2 | 2001-11-06 |
Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester Grant 6,268,207 - Bailey July 31, 2 | 2001-07-31 |
Azetidinone derivatives for the treatment of HCMV infections Grant 6,239,125 - Malenfant , et al. May 29, 2 | 2001-05-29 |
Azetidinone derivatives for the treatment of HCMV infections Grant 6,211,170 - Yoakim , et al. April 3, 2 | 2001-04-03 |
Hepatitis C inhibitor peptide analogues Grant 6,143,715 - Llinas-Brunet , et al. November 7, 2 | 2000-11-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.